MY-5445 explained

MY-5445 is a relatively specific phosphodiesterase 5 inhibitor.[1] [2]

See also

Notes and References

  1. Nagendran . J . Archer . SL . Soliman . D . Gurtu . V . Moudgil . R . Haromy . A . St. Aubin . C . Webster . L . Rebeyka . IM . Ross . DB . Light . PE . Dyck . JR . Michelakis . ED . Phosphodiesterase Type 5 is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility . Circulation . 17 July 2007 . 116 . 3 . 238–48 . 10.1161/circulationaha.106.655266 . 17606845 . 7612061 . free .
  2. Hagiwara . M . Endo . T . Kanayama . T . Hidaka . H . Effect of 1-(3-Chloroanilino)-4-phenylphthalazine (MY-5445), a Specific Inhibitor of Cyclic GMP Phosphodiesterase, on Human Platelet Aggregation . The Journal of Pharmacology and Experimental Therapeutics . February 1984 . 228 . 2 . 467–71 . 6141286.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "MY-5445".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.